Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Trudhesa™ (dihydroergotamine mesylate) – New drug approval
September 3, 2021 - Impel NeuroPharma announced the FDA approval of Trudhesa (dihydroergotamine mesylate) nasal spray, for the acute treatment of migraine with or without aura in adults.
